Goldman, Sachs

Goldman Sachs Builds Stake in Kontron Amid Share Price Weakness

28.03.2026 - 10:26:54 | boerse-global.de

Kontron shares rebound after Goldman Sachs discloses a 4.43% stake and the board announces a €50M buyback, countering pressure from a cautious 2026 outlook.

Goldman Sachs Builds Stake in Kontron Amid Share Price Weakness - Foto: über boerse-global.de

Significant buying activity from both corporate leadership and a major Wall Street institution is providing support for Kontron's shares, which have faced substantial pressure following a cautious financial outlook.

A Strategic Move at a Low Point

The Goldman Sachs Group has established a notable position in the technology firm, reporting a holding equivalent to 4.43% of voting rights. The bulk of this stake was acquired through financial instruments such as swaps. This regulatory disclosure coincided with a stabilization in the share price. After hitting a fresh 52-week low of €18.00 on Thursday, the stock recovered, closing Friday's session at €18.74—a gain of 4.11%.

Cautious Forecast Tempers Investor Sentiment

The recent volatility was triggered by the company's guidance for the 2026 fiscal year. Despite posting a 15% increase in adjusted EBITDA to €220.5 million for 2025, the new targets disappointed the market. Management described the coming period as a "transition year," projecting an EBITDA of approximately €225 million on revenue of up to €1.8 billion.

Should investors sell immediately? Or is it worth buying Kontron?

These figures fell short of prior consensus estimates, contributing to a year-to-date decline in the equity's value of more than 20%. A record order backlog of €2.5 billion, heavily supported by growth in the Defense and Transport segments, is cited as a stabilizing fundamental factor.

Management and Analyst Responses

To counteract selling pressure, Kontron's board announced a share buyback program with a volume of up to €50 million. This action is complemented by CEO Hannes Niederhauser, who has expanded his personal holding through market purchases.

Several prominent research firms have revised their models in light of the updated guidance but maintain positive ratings:

  • mwb research: Reduced price target from €36.00 to €34.00
  • DZ Bank: Lowered fair value estimate from €33.00 to €31.00
  • Jefferies: Maintained price target at €27.00

The executive board reaffirmed its long-term "Vision 2030," which aims for an operating result of €420 million. With the initiation of the buyback and the fundamental backing of a multi-billion-euro order book, management has taken concrete steps to underpin the valuation at current levels.

Ad

Kontron Stock: New Analysis - 28 March

Fresh Kontron information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Kontron analysis...

So schätzen die Börsenprofis Goldman Aktien ein!

<b>So schätzen die Börsenprofis Goldman Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
AT0000A0E9W5 | GOLDMAN | boerse | 69012472 |

Weitere Meldungen

ANALYSE-FLASH: Goldman senkt Ziel für Henkel auf 70 Euro - 'Sell' Die US-Investmentbank Goldman Sachs hat das Kursziel für Henkel DE0006048432 vor Quartalszahlen von 73 auf 70 Euro gesenkt und die Einstufung auf "Sell" belassen. (Boerse, 02.04.2026 - 12:35) weiterlesen...

ANALYSE-FLASH: Goldman hebt Ziel für Evonik auf 20 Euro - 'Buy' Die US-Investmentbank Goldman Sachs hat das Kursziel für Evonik DE000EVNK013 vor Quartalszahlen von 18 auf 20 Euro angehoben und die Einstufung auf "Buy" belassen. (Boerse, 02.04.2026 - 11:20) weiterlesen...

ANALYSE-FLASH: Goldman hebt Rheinmetall auf 'European Conviction List' - 'Buy' Die US-Investmentbank Goldman Sachs hat die Rheinmetall-Aktie DE0007030009 in die "European Conviction List" für besonders aussichtsreiche Werte aufgenommen. (Boerse, 01.04.2026 - 19:05) weiterlesen...

AKTIE IM FOKUS: Goldman Sachs treibt kräftige Rheinmetall-Erholung voran Die Aktie von Rheinmetall DE0007030009 hat sich am Mittwoch im freundlichen Gesamtmarkt weiter von ihrem am Montag erreichten Elf-Monats-Tief nach oben hin abgesetzt. (Boerse, 01.04.2026 - 16:51) weiterlesen...

ANALYSE-FLASH: Goldman senkt Ziel für Lanxess auf 21 Euro - 'Neutral' Die US-Investmentbank Goldman Sachs hat das Kursziel für Lanxess DE0005470405 vor Zahlen zum ersten Quartal von 23 auf 21 Euro gesenkt und die Einstufung auf "Neutral" belassen. (Boerse, 01.04.2026 - 12:34) weiterlesen...

ANALYSE-FLASH: Goldman hebt Sartorius Stedim Biotech auf 'Buy' - Ziel gesenkt Die US-Investmentbank Goldman Sachs hat das Kursziel für Sartorius Stedim FR0013154002 von 235 auf 214 Euro gesenkt, die Aktien aber von "Neutral" auf "Buy" hochgestuft. (Boerse, 30.03.2026 - 09:04) weiterlesen...